Perrigo | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
AbbVie USD 5.52B 1.73B 2024-12
Abbott USD 7.62B 58M 2024-12
Bayer EUR 6.19B 1.57B 2024-12
Bristol-Myers Squibb USD 10.35B 2.46B 2024-12
Corcept Therapeutics USD 127.66M 9.62M 2024-12
Dr.Reddys Laboratories INR 13.03B 1.7B 2024-12
Eli Lilly USD 3.27B 100.6M 2024-12
J&J USD 6.12B 1.28B 2024-12
Merck USD 13.24B 1.35B 2024-12
Nestle CHF 5.56B 691M 2024-12
Pacira USD 276.77M 30.81M 2024-12
Perrigo USD 558.8M 904.7M 2024-12
Pfizer USD 1.04B 49M 2024-12
Prestige Brands USD 50.87M 666K 2024-12
Reckitt Benckiser GBP 880M 106M 2024-12
Sanofi 6.8B 1.92B 2024-06
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
Teva Pharmaceutical Industries USD 3.3B 19M 2024-12
Xeris Pharmaceuticals USD 71.62M 12.39M 2024-12
Zoetis USD 1.98B 275M 2024-12



Perrigo Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.